Deep Tech Startups

Bluewake manufactures a patented blue light device designed to combat drowsiness and enhance alertness without caffeine or pharmaceuticals, primarily targeting drivers and transportation fleets to reduce accident risk.

1 investor

BluGlass publishes investor webcasts featuring interviews with its executive staff, distributed through the Finance News Network.

1 investor

Blurry is a browser-based cloud platform for hosting, sharing, annotating, and collaborating on large 3D Gaussian Splatting models, with level-of-detail streaming to handle scans with millions of splats. It targets teams documenting physical spaces such as construction sites, crime scenes, and real estate.

1 investor

b.next develops technologies and infrastructure for building synthetic cells from scratch, working with researchers, universities, governments, and funders. It operates Nucleus, an open technology platform providing materials, protocols, documentation, and software for engineering synthetic cells.

1 investor

BnH Research develops therapeutics for chronic conditions with an initial focus on central nervous system disorders such as Alzheimer's Disease, PTSD, addiction, amblyopia, and stroke, with drug candidates aimed at reopening cortical plasticity. It also provides contract-based research services offering drug efficacy validation data to pharmaceutical companies in early-stage drug discovery, based in South Korea.

1 investor

bNovate Technologies builds online flow cytometry systems for real-time microbiological water monitoring, providing continuous measurement of microbial water quality in place of delayed lab testing. It serves water utilities, food and beverage, pharmaceutical and cosmetic manufacturers, and academic researchers, and is based in Switzerland.

1 investor

Boltz PBC develops frontier AI models and high-performance compute infrastructure for biomolecular modeling and design, including small-molecule screening and hit discovery. Its tools, available via an API, serve drug discovery and scientific research teams.

1 investor

BOM is a venture capital and venture development firm that invests patient capital and provides hands-on support to early-stage and scale-up companies in the Netherlands. The firm focuses on three investment domains: Key Technologies (deeptech and AI), Climate Tech (renewable energy and plant-based solutions), and Medtech & Life Sciences.

1 investor

Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools. The company is building a multi-disease pipeline initially focused on neurodegenerative diseases.

1 investor

Borea Therapeutics develops gene therapy delivery technologies based on a proprietary AAV conjugation platform targeting neurological and genetic diseases. The company serves the therapeutic biotechnology market with precision neuronal targeting and advanced delivery strategies.

1 investor

Boréas develops piezo haptic driver chips and integration solutions, including its CapDrive technology, for device makers building solid-state buttons, AI/AR glasses, and microfluidic cooling systems. The company provides reference architectures that combine drivers, sensing algorithms, and mechanical mounting to help hardware teams integrate high-definition haptics and thermal management into compact devices.

1 investor

Bornea Dynamics provides research and development, AI/machine learning, engineering, and cyber intelligence services across mechatronics, electrical, and chemical disciplines. The company serves industrial clients seeking custom technical solutions and professional training.

1 investor

Bosonic is developing computing and hardware infrastructure aimed at giving innovators access to advanced computational resources for testing and building ideas. The company's public messaging focuses on connecting people to hardware and computation, though the page provides limited concrete product detail.

1 investor

Bosonic is working on quantum computing with a stated first stage focused on making quantum computers more accessible, connected, and powerful for people building and testing new ideas.

1 investor

Boston Micromachines manufactures deformable mirrors and intensity modulation components based on MEMS technology for research and optical applications. The company offers both standard products and custom technology development services.

1 investor

BotLab Dynamics designs and operates large-scale autonomous drone systems for entertainment and light shows, leveraging indigenous Indian technology. The company provides experiential events and drone control systems for global markets.

1 investor

Boulder AI builds edge computing devices that combine sensors, on-device AI inference, and cloud orchestration to analyze high-resolution scenes locally and transmit reduced, contextual insights. The company offers AI-enabled cameras and compute nodes with an enterprise software stack and app store for managing analytics across large fleets of IoT devices.

1 investor

Bow Capital is a University of California ecosystem venture fund that backs early-stage founders building AI for physical, industrial, and biological applications, including robotics, defense, healthcare, and logistics. It sources deals from the UC system's faculty, students, and alumni and runs a UC San Diego incubator focused on national security through science, robotics, and manufacturing.

1 investor

Bohr Quantum Technology develops quantum-native cyberdefense hardware and software for critical infrastructure networks. The company provides an end-to-end quantum network stack with key distribution, deployable nodes, and lifecycle support for quantum-secure communications.

1 investor

Brain.space develops brain monitoring hardware and a Brain-Data-as-a-Service platform that collects and analyzes standardized brain data to create large mental models for predicting human behavior. The company serves medical and research applications in neuroscience and mental health.

1 investor

BrainChip develops Akida, a digital neuromorphic processor and edge AI IP that runs AI models on ultra-low-power, small form factor devices. It licenses this technology for applications across industrial IoT, healthcare, automotive, defense, and space markets.

1 investor

BrainVivo develops neurotech that converts MRI brain scan data into algorithmic models to digitize and preserve individual human wisdom. The company serves individuals and organizations seeking access to personalized cognitive intelligence models.

1 investor

Bramante Bio manufactures AI-driven robotic instruments and reagents for life sciences research and manufacturing. The company designs hardware that integrates with modern software stacks and provides direct engineering support.

1 investor

Brandaris Therapeutics is a translational-stage biotech developing first-in-class and best-in-class small-molecule therapies for neuropsychiatric disorders such as depression and anxiety, using a differentiated approach to receptor pharmacology. Its drug candidates aim to provide rapid-onset, durable efficacy with improved side-effect profiles for patients with mental health disorders.

1 investor